Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Decision Diagnostics Corp DECN

Decision Diagnostics Corp. is specialized in prescription, non-prescription diagnostics and home testing products. The Company is a provider of prescription drugs, home testing products for the chronically ill, a fulfillment provider of direct to patient diabetes programs, and a developer of cell phone centric, e-health products and technology. Through its subsidiary, PharmaTech Solutions, Inc.... see more

GREY:DECN - Post Discussion

View:
Post by satchmo6 on Apr 01, 2022 8:54pm

IRS

The IR Service has been sending me letters every 3 months---they are so ignorant and stupid--a bad combination-------4 years they have been delaying paying me money they withheld on sale of recreation property---

they must think i lived there---so ignorant that they think i lie over 7,000 dollars.   disgusting---I NEVER WILL GO TO THE USA AGAIN

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities